Expanding our Knowledge of Viral Epidemics
At Ayass BioScience, LLC we are dedicated to expanding our knowledge of viral epidemics in order to support our community by understanding the specificity of SARS-CoV-2 mutations. Therefore we are using Next-generation sequencing (NGS) to provide an effective way to learn more about this rapidly spreading virus and how mutations affect its functions. The diverse structure of the virus in our positive patients will help us understand from where the new cases came to Texas.
of SARS-CoV-2 Viruses
This phylogenetic tree, generated by Nextstrain using the data from GISAID, shows evolutionary relationships of SARS-CoV-2 viruses from the ongoing COVID-19 pandemic, initially emerging in Nov-Dec 2019 in Wuhan, China, followed by human-to-human transmission shown in sampled infections.
Our Work on NGS for All COVID-19 Tested Positive Reveals Similarities with Sequencing Results Conducted and Published in Europe
After sequencing samples positive for COVID-19, Ayass BioScience, LLC was able to identify similar sequences made available in the publicly accessible GISAID EpiCoV database, allowing us to pinpoint the specific areas of the phylogenetic tree where our samples may have originated from. Our work on NGS for the majority of COVID-19 positive tested samples reveals similarities with sequencing results conducted and published in Europe, while a smaller number of samples were more closely related to a strain coming from China.
We Aim to Assist Our Scientific Community
As we here at Ayass BioScience, LLC continue to identify and sequence positive samples, we hope to deepen our understanding of the COVID-19 pandemic by studying unique variants that may contribute to disease virulence and genetic diversity. By doing so, we aim to assist the scientific community by improving understanding of the implications of different viral strains, eventually leading to more specific care for affected individuals.